Central Region, Central, Singapore The main office of represented Corporate Investor is situated in the Singapore. The fund was located in Asia if to be more exact in Singapore.
The standard case for the fund is to invest in rounds with 6 partakers. The meaningful sponsors for the fund in investment in the same round are Rothschild Australian Bioscience Trust, International Biotechnology Trust, CSL.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2000.
Among the most popular portfolio startups of the fund, we may highlight eBioinformatics. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Information Services, Bioinformatics. Besides, a startup requires to be at the age of 1 and less years to receive the investment from the fund.
| Fund Name | Location |
| Applied Technology Investors | Lexington, Massachusetts, United States |
| Gezina | Norway, Oslo |
| Innovius Capital | California, San Francisco, United States |
| Overture Wealth | China, Guangdong, Shenzhen |
| Prelude Growth Partners | New York, New York, United States |
| SF Capital | Guildford, Surrey, United Kingdom |
| Talma Travel and Tours | Illinois, Illinois City, United States |
| Valiant Capital Partners | California, San Francisco, United States |
| West Quad Ventures | New York, New York, United States |
| Zhengyuan Celue Touzi | Bayi, China, Tibet |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 